Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 20, 2025 | (Q2)Sep 20, 2024 | (Q1)Jun 20, 2024 | (FY)Mar 20, 2024 | (Q4)Mar 20, 2024 | (Q3)Dec 20, 2023 | (Q2)Sep 20, 2023 | (Q1)Jun 20, 2023 | (FY)Mar 20, 2023 | (Q4)Mar 20, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.26%55.99B | -2.38%14.52B | -4.53%14.3B | 2.00%57.88B | 0.61%12.97B | 4.24%15.06B | 2.70%14.88B | 0.34%14.98B | -18.21%56.75B | -17.13%12.89B |
| Cost of revenue | -1.13%41.17B | -0.15%10.6B | -5.13%10.21B | -4.64%41.64B | -4.36%9.69B | -5.94%10.57B | -5.68%10.62B | -2.51%10.76B | -21.96%43.67B | -22.70%10.13B |
| Gross profit | -8.72%14.83B | -7.92%3.92B | -3.01%4.09B | 24.15%16.24B | 18.91%3.28B | 39.86%4.49B | 31.92%4.26B | 8.44%4.21B | -2.59%13.08B | 12.56%2.76B |
| Operating expense | 1.78%10.98B | 1.33%2.73B | 7.50%2.77B | -0.80%10.78B | 6.61%2.76B | 0.69%2.75B | -2.35%2.7B | -7.61%2.57B | 0.50%10.87B | -2.04%2.59B |
| Operating profit | -29.47%3.85B | -23.93%1.19B | -19.51%1.32B | 146.81%5.46B | 202.89%524M | 265.82%1.73B | 235.99%1.56B | 49.09%1.64B | -15.38%2.21B | 191.53%173M |
| Net non-operating interest income (expenses) | -23.60%-419M | -30.67%-98M | -11.43%-78M | -11.88%-339M | -8.62%-126M | -6.25%-68M | -22.95%-75M | -12.90%-70M | -5.21%-303M | -10.48%-116M |
| Non-operating interest income | 73.33%26M | -20.00%4M | 125.00%9M | 650.00%15M | ---2M | 700.00%8M | 400.00%5M | --4M | -33.33%2M | --0 |
| Non-operating interest expense | 29.26%402M | 27.50%102M | 17.57%87M | 19.16%311M | 12.50%81M | 16.92%76M | 29.03%80M | 19.35%74M | 7.41%261M | 24.14%72M |
| Total other finance cost | 0.00%43M | ---- | ---- | -2.27%43M | ---- | ---- | ---- | ---- | -8.33%44M | ---- |
| Net investment income | 41.01%392M | -32.29%151M | 515.38%160M | -45.91%278M | 22.64%-82M | -33.93%111M | -21.20%223M | -84.62%26M | 44.38%514M | -237.66%-106M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -160.53%-227M | 116M | 0 | 126.22%375M | 231.89%244M | 0 | 0 | 669.57%131M | -331.77%-1.43B | -77.88%-185M |
| Less:Restructuring and mergern&acquisition | 11.45%-116M | ---116M | --0 | ---131M | --0 | --0 | --0 | ---131M | --0 | --0 |
| Less:Other special charges | 240.57%343M | ---- | ---- | -118.53%-244M | ---- | ---- | ---- | ---- | 290.87%1.32B | 5.88%72M |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 54.79%113M | ---- |
| Other non-operating income (expenses) | 48.10%117M | 92.00%-2M | 134.21%13M | 125.71%79M | -6.33%148M | 93.10%-6M | -78.57%-25M | -72.73%-38M | -68.75%35M | 229.17%158M |
| Income before tax | -36.53%3.71B | -19.58%1.35B | -16.20%1.42B | 470.73%5.85B | 1,030.26%707M | 488.70%1.77B | 564.09%1.68B | 45.52%1.69B | -69.92%1.03B | 72.26%-76M |
| Income tax | -38.11%588M | 35.55%347M | -15.76%417M | 36.69%950M | 132.40%58M | -38.96%141M | 4.07%256M | 24.69%495M | -42.18%695M | -237.74%-179M |
| Net income | -36.24%3.12B | -29.56%1B | -16.32%1B | 1,389.36%4.9B | 537.25%650M | 2,230.00%1.63B | 334.21%1.42B | 56.21%1.2B | -85.08%329M | 145.95%102M |
| Net income continuous operations | -36.22%3.13B | -29.49%1B | -16.39%1B | 1,384.85%4.9B | 530.10%649M | 2,230.00%1.63B | 334.21%1.42B | 56.34%1.2B | -85.04%330M | 146.61%103M |
| Noncontrolling interests | -81.25%36M | -62.96%30M | -63.64%28M | 149.35%192M | -168.09%-32M | 66M | 1,257.14%81M | 108.11%77M | 260.42%77M | 136.15%47M |
| Net income attributable to the company | -34.40%3.09B | -27.55%973M | -13.15%971M | 1,767.86%4.71B | 1,140.00%682M | 2,102.82%1.56B | 323.09%1.34B | 53.57%1.12B | -88.82%252M | 160.44%55M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -34.40%3.09B | -27.55%973M | -13.15%971M | 1,767.86%4.71B | 1,140.00%682M | 2,102.82%1.56B | 323.09%1.34B | 53.57%1.12B | -88.82%252M | 160.44%55M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -34.55%739.09 | -27.62%233.44 | -12.88%232.85 | 1,773.90%1.13K | 1,147.79%163.46 | 2,129.89%375.96 | 324.53%322.52 | 53.66%267.27 | -88.81%60.26 | 160.04%13.1 |
| Diluted earnings per share | -34.55%739.09 | -27.27%233.2945 | -12.88%232.85 | 1,773.90%1.13K | 1,147.79%163.46 | 2,129.89%375.96 | 323.09%320.7889 | 53.66%267.27 | -88.81%60.26 | 160.04%13.1 |
| Dividend per share | 8.33%65 | 0 | 0 | 71.43%60 | 71.43%60 | 0 | 0 | 0 | -22.22%35 | -22.22%35 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |